{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:40:03Z","timestamp":1787060403827,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:00:00Z","timestamp":1538611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:00:00Z","timestamp":1538611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Procaspase-3-activating compound 1 (PAC-1) induces procaspase-3 activation via zinc chelation. However, whether PAC-1 employs other mechanisms remains unknown. Here we systematically screened for potent PAC-1 targets using 29 enhanced green fluorescent protein-labeled reporter cell lines and identified hypoxia-inducible factor 1\u03b1 (HIF1\u03b1) and RAD51 pathways as PAC-1 targets. These results were verified in HepG2 cells and two other cancer cell lines. Mechanistically, PAC-1 specifically blocked HIF1\u03b1 hydroxylation and upregulated HIF1\u03b1 target genes. In addition, DNA damage, G\n                    <jats:sub>1<\/jats:sub>\n                    \/S cell cycle arrest, and the inhibition of DNA synthesis were induced following PAC-1 administration. Interestingly, by using ferrozine-iron sequestration and iron titration assays, we uncovered the iron sequestering capacity of PAC-1. Additionally, the expression levels of iron shortage-related genes were also increased in PAC-1-treated cells, and iron (II) supplementation reversed all of the observed cellular responses. Thus, our results indicate that PAC-1 induces HIF1\u03b1 stabilization and DNA damage by sequestering ferrous iron.\n                  <\/jats:p>","DOI":"10.1038\/s41419-018-1038-3","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T10:24:36Z","timestamp":1538648676000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Procaspase-3-activating compound 1 stabilizes hypoxia-inducible factor 1\u03b1 and induces DNA damage by sequestering ferrous iron"],"prefix":"10.1038","volume":"9","author":[{"given":"Feifei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aili","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,4]]},"reference":[{"key":"1038_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/carcin\/21.3.485","volume":"21","author":"SW Lowe","year":"2000","unstructured":"Lowe, S. W. & Lin, A. W. Apoptosis in cancer. Carcinogenesis 21, 485\u2013495 (2000).","journal-title":"Carcinogenesis"},{"key":"1038_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nchembio814","volume":"2","author":"KS Putt","year":"2006","unstructured":"Putt, K. S. et al. Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat. Chem. Biol. 2, 543\u2013550 (2006).","journal-title":"Nat. Chem. Biol."},{"key":"1038_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1021\/co2001372","volume":"14","author":"DC Hsu","year":"2012","unstructured":"Hsu, D. C. et al. Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1). ACS Comb. Sci. 14, 44\u201350 (2012).","journal-title":"ACS Comb. Sci."},{"key":"1038_CR4","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1158\/0008-5472.CAN-10-0766","volume":"70","author":"QP Peterson","year":"2010","unstructured":"Peterson, Q. P. et al. Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound. Cancer Res. 70, 7232\u20137241 (2010).","journal-title":"Cancer Res."},{"key":"1038_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1126\/science.1177585","volume":"326","author":"DW Wolan","year":"2009","unstructured":"Wolan, D. W., Zorn, J. A., Gray, D. C. & Wells, J. A. Small-molecule activators of a proenzyme. Science 326, 853\u2013858 (2009).","journal-title":"Science"},{"key":"1038_CR6","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.molonc.2014.06.015","volume":"8","author":"F Wang","year":"2014","unstructured":"Wang, F. et al. A novel small-molecule activator of procaspase-3 induces apoptosis in cancer cells and reduces tumor growth in human breast, liver and gallbladder cancer xenografts. Mol. Oncol. 8, 1640\u20131652 (2014).","journal-title":"Mol. Oncol."},{"key":"1038_CR7","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1016\/j.bmc.2013.06.037","volume":"21","author":"OA Strand","year":"2013","unstructured":"Strand, O. A. et al. Synthesis and initial in vitro biological evaluation of two new zinc-chelating compounds: comparison with TPEN and PAC-1. Bioorg. Med. Chem. 21, 5175\u20135181 (2013).","journal-title":"Bioorg. Med. Chem."},{"key":"1038_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nchembio0907-519","volume":"3","author":"JB Denault","year":"2007","unstructured":"Denault, J. B. et al. Small molecules not direct activators of caspases. Nat. Chem. Biol. 3, 519 (2007). author reply 520.","journal-title":"Nat. Chem. Biol."},{"key":"1038_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jmb.2009.03.003","volume":"388","author":"QP Peterson","year":"2009","unstructured":"Peterson, Q. P. et al. PAC-1 activates procaspase-3 in vitro through relief of zinc-mediated inhibition. J. Mol. Biol. 388, 144\u2013158 (2009).","journal-title":"J. Mol. Biol."},{"key":"1038_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1039\/C5TX00305A","volume":"5","author":"L Long","year":"2016","unstructured":"Long, L. et al. Dynamic cytotoxic profiles of sulfur mustard in human dermal cells determined with multiparametric high-content analysis. Toxicol. Res. 5, 583\u2013593 (2016).","journal-title":"Toxicol. Res."},{"key":"1038_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2174\/138620711796367247","volume":"14","author":"C Wang","year":"2011","unstructured":"Wang, C., Wang, L. & Zhao, C. Development of a plate-based assay for high-content analysis of individual untethered non-adherent cells. Comb. Chem. High Throughput Screen. 14, 583\u2013589 (2011).","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"1038_CR12","doi-asserted-by":"publisher","first-page":"e14124","DOI":"10.1371\/journal.pone.0014124","volume":"5","author":"J Meng","year":"2010","unstructured":"Meng, J. et al. Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo. PLoS ONE 5, e14124 (2010).","journal-title":"PLoS ONE"},{"key":"1038_CR13","doi-asserted-by":"publisher","first-page":"e96056","DOI":"10.1371\/journal.pone.0096056","volume":"9","author":"W Chen","year":"2014","unstructured":"Chen, W. et al. Novel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamster. PLoS ONE 9, e96056 (2014).","journal-title":"PLoS ONE"},{"key":"1038_CR14","doi-asserted-by":"crossref","first-page":"re12","DOI":"10.1126\/stke.3062005re12","volume":"2005","author":"RH Wenger","year":"2005","unstructured":"Wenger, R. H., Stiehl, D. P. & Camenisch, G. Integration of oxygen signaling at the consensus HRE. Sci. STKE 2005, re12 (2005).","journal-title":"Sci. STKE"},{"key":"1038_CR15","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nrc2523","volume":"8","author":"WM Bonner","year":"2008","unstructured":"Bonner, W. M. et al. GammaH2AX and cancer. Nat. Rev. Cancer 8, 957\u2013967 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"1038_CR16","doi-asserted-by":"publisher","first-page":"38102","DOI":"10.1074\/jbc.M504342200","volume":"280","author":"KK To","year":"2005","unstructured":"To, K. K. & Huang, L. E. Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1. J. Biol. Chem. 280, 38102\u201338107 (2005).","journal-title":"J. Biol. Chem."},{"key":"1038_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canlet.2009.12.019","volume":"293","author":"JB Jeong","year":"2010","unstructured":"Jeong, J. B., De Lumen, B. O. & Jeong, H. J. Lunasin peptide purified from Solanum nigrum L. protects DNA from oxidative damage by suppressing the generation of hydroxyl radical via blocking fenton reaction. Cancer Lett. 293, 58\u201364 (2010).","journal-title":"Cancer Lett."},{"key":"1038_CR18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nrd3845","volume":"11","author":"J Bowes","year":"2012","unstructured":"Bowes, J. et al. Reducing safety-related drug attrition: the use of in vitro pharmacological profiling. Nat. Rev. Drug Discov. 11, 909\u2013922 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1038_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01657-3","volume":"8","author":"JL Dahlin","year":"2017","unstructured":"Dahlin, J. L. & Nelson, K. M. Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors. Nat. Commun. 8, 1527 (2017).","journal-title":"Nat. Commun."},{"key":"1038_CR20","doi-asserted-by":"publisher","first-page":"cm8","DOI":"10.1126\/stke.4072007cm8","volume":"2007","author":"GL Semenza","year":"2007","unstructured":"Semenza, G. L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, cm8 (2007).","journal-title":"Sci. STKE"},{"key":"1038_CR21","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1242\/jcs.00655","volume":"116","author":"N Masson","year":"2003","unstructured":"Masson, N. & Ratcliffe, P. J. HIF prolyl and asparaginyl hydroxylases in the biological response tointracellular O2 levels. J. Cell Sci. 116, 3041 (2003).","journal-title":"J. Cell Sci."},{"key":"1038_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1039\/b511249b","volume":"1","author":"LA Mcneill","year":"2005","unstructured":"Mcneill, L. A. et al. Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate. Mol. Biosyst. 1, 321\u2013324 (2005).","journal-title":"Mol. Biosyst."},{"key":"1038_CR23","doi-asserted-by":"crossref","unstructured":"Ono, S. et al. Effect of Deferoxamine-activated Hypoxia Inducible Factor-1 on the Brainstem Following Subarachnoid Haemorrhage (Springer, Vienna, 2008).","DOI":"10.1007\/978-3-211-75718-5_13"},{"key":"1038_CR24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/513481a","volume":"513","author":"J Baell","year":"2014","unstructured":"Baell, J. & Walters, M. A. Chemistry: chemical con artists foil drug discovery. Nature 513, 481\u2013483 (2014).","journal-title":"Nature"},{"key":"1038_CR25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nrd4737","volume":"14","author":"SV Frye","year":"2015","unstructured":"Frye, S. V. et al. Tackling reproducibility in academic preclinical drug discovery. Nat. Rev. Drug Discov. 14, 733 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1038_CR26","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1021\/jm900722z","volume":"52","author":"QP Peterson","year":"2009","unstructured":"Peterson, Q. P. et al. Procaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with caspase-3. J. Med. Chem. 52, 5721\u20135731 (2009).","journal-title":"J. Med. Chem."},{"key":"1038_CR27","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1021\/ic060014r","volume":"45","author":"LK Charkoudian","year":"2006","unstructured":"Charkoudian, L. K. & Franz, K. J. Fe(III)-coordination properties of neuromelanin components: 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid. Inorg. Chem. 45, 3657\u20133664 (2006).","journal-title":"Inorg. Chem."},{"key":"1038_CR28","doi-asserted-by":"publisher","first-page":"12424","DOI":"10.1021\/ja064806w","volume":"128","author":"LK Charkoudian","year":"2006","unstructured":"Charkoudian, L. K., Pham, D. M. & Franz, K. J. A pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation. J. Am. Chem. Soc. 128, 12424\u201312425 (2006).","journal-title":"J. Am. Chem. Soc."},{"key":"1038_CR29","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1039\/C5CC00829H","volume":"51","author":"R Gautam","year":"2015","unstructured":"Gautam, R., Akam, E. A., Astashkin, A. V., Loughrey, J. J. & Tomat, E. Sirtuin inhibitor sirtinol is an intracellular iron chelator. Chem. Commun. (Camb.). 51, 5104\u20135107 (2015).","journal-title":"Chem. Commun. (Camb.)."},{"key":"1038_CR30","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.bbrc.2006.03.039","volume":"343","author":"SM Choi","year":"2006","unstructured":"Choi, S. M., Choi, K. O., Lee, N., Oh, M. & Park, H. The zinc chelator, N,N,N\u2019,N\u2019-tetrakis (2-pyridylmethyl) ethylenediamine, increases the level of nonfunctional HIF-1alpha protein in normoxic cells. Biochem. Biophys. Res. Commun. 343, 1002\u20131008 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1038_CR31","doi-asserted-by":"publisher","first-page":"26831","DOI":"10.1074\/jbc.M109.009498","volume":"284","author":"KM Cook","year":"2009","unstructured":"Cook, K. M. et al. Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism. J. Biol. Chem. 284, 26831\u201326838 (2009).","journal-title":"J. Biol. Chem."},{"key":"1038_CR32","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/0024-3205(92)90572-7","volume":"50","author":"T Furukawa","year":"1992","unstructured":"Furukawa, T., Naitoh, Y., Kohno, H., Tokunaga, R. & Taketani, S. Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis. Life Sci. 50, 2059\u20132065 (1992).","journal-title":"Life Sci."},{"key":"1038_CR33","first-page":"31","volume":"1603","author":"NTV Le","year":"2002","unstructured":"Le, N. T. V. & Richardson, D. R. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim. Biophys. Acta 1603, 31\u201346 (2002).","journal-title":"Biochim. Biophys. Acta"},{"key":"1038_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/156800906777723949","volume":"6","author":"J Shao","year":"2006","unstructured":"Shao, J., Zhou, B., Chu, B. & Yen, Y. Ribonucleotide reductase inhibitors and future drug design. Curr. Cancer Drug Targets 6, 409\u2013431 (2006).","journal-title":"Curr. Cancer Drug Targets"},{"key":"1038_CR35","first-page":"4591","volume":"52","author":"KP Hoyes","year":"1992","unstructured":"Hoyes, K. P., Hider, R. C. & Porter, J. B. Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell lines. Cancer Res. 52, 4591\u20134599 (1992).","journal-title":"Cancer Res."},{"issue":"5","key":"1038_CR36","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/0884533610379857","volume":"25","author":"Khalil El-Chammas","year":"2010","unstructured":"El\u3024Hammas, K. Book Review: Iron Deficiency and Overload: From Basic Biology to Clinical Medicine. Nutrition in Clinical Practice 25, 562\u2013562 (2010).","journal-title":"Nutrition in Clinical Practice"},{"key":"1038_CR37","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.1073\/pnas.1015686108","volume":"108","author":"Y Qin","year":"2011","unstructured":"Qin, Y., Dittmer, P. J., Park, J. G., Jansen, K. B. & Palmer, A. E. Measuring steady-state and dynamic endoplasmic reticulum and Golgi Zn2\u2009+\u2009with genetically encoded sensors. Proc. Natl. Acad. Sci. USA 108, 7351\u20137356 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1038-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1038-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1038-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:21:28Z","timestamp":1671520888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1038-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,4]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["1038"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1038-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,4]]},"assertion":[{"value":"10 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1025"}}